Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
10.75
+0.03 (0.28%)
At close: Nov 20, 2024, 4:00 PM
10.90
+0.15 (1.40%)
Pre-market: Nov 21, 2024, 7:30 AM EST
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $1.04 billion as of November 21, 2024. Its market cap has increased by 11.67% in one year.
Market Cap
1.04B
Enterprise Value
1.01B
1-Year Change
11.67%
Ranking
Category
Stock Price
$10.75
Market Cap Chart
Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $1.04B, an increase of 1,369.34%. That is a compound annual growth rate of 13.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 1.04B | -18.31% |
Dec 29, 2023 | 1.27B | 186.71% |
Dec 30, 2022 | 442.30M | -6.63% |
Dec 31, 2021 | 473.70M | 21.68% |
Dec 31, 2020 | 389.30M | 37.71% |
Dec 31, 2019 | 282.70M | 196.02% |
Dec 31, 2018 | 95.50M | -70.71% |
Dec 29, 2017 | 326.10M | -23.90% |
Dec 30, 2016 | 428.50M | -12.68% |
Dec 31, 2015 | 490.70M | 11.85% |
Dec 31, 2014 | 438.70M | 118.37% |
Dec 31, 2013 | 200.90M | 165.74% |
Dec 31, 2012 | 75.60M | -41.12% |
Dec 30, 2011 | 128.40M | -22.88% |
Dec 31, 2010 | 166.50M | -7.04% |
Dec 31, 2009 | 179.10M | 89.93% |
Dec 31, 2008 | 94.30M | -60.61% |
Dec 31, 2007 | 239.40M | -66.28% |
Dec 29, 2006 | 710.00M | 72.88% |
Dec 30, 2005 | 410.70M | -1.49% |
Dec 31, 2004 | 416.90M | -3.92% |
Dec 31, 2003 | 433.90M | 515.46% |
Dec 31, 2002 | 70.50M | - |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pharvaris | 1.08B |
OPKO Health | 1.08B |
ANI Pharmaceuticals | 1.08B |
Phreesia | 1.07B |
The Pennant Group | 1.05B |
Brookdale Senior Living | 1.04B |
Weave Communications | 1.01B |
Cogent Biosciences | 1.01B |